Abstract
Achieving maternal and newborn health (MNH) related Sustainable Development Goal targets will require high-quality health systems in low– and middle-income countries. While over 90% of deliveries in Rwanda take place in health facilities, maternal and neonatal mortality rates remain high. In an effort to bolster quality of care provided to women and newborns to ultimately reduce morbidity and mortality, the Training, Support and Access Model (TSAM) clinical mentorship was established in 10 district hospitals in Rwanda in 2017. We evaluated the impact of the TSAM clinical mentorship intervention on maternal and newborn health outcomes. We used monthly time series data from the DHIS2-enabled Rwanda health management information system from February 2014 to February 2020 to assess the impact of the TSAM intervention on outcomes of care for MNH in intervention hospitals relative to concurrent control hospitals. Using a controlled quasi-experimental interrupted time series analysis, we estimated changes in rates of inpatient mortality and morbidity for MNH associated with the implementation of the TSAM clinical mentorship. The study cohort included 25 hospitals (10 TSAM hospitals and 15 control hospitals) that collectively reported 339,850 hospital deliveries and 94,584 neonatal hospital admissions. We found that the implementation of the TSAM clinical mentorship intervention was associated with a two-years reduction of 84% in the obstetrical complication case fatality rate, 32% in hospital neonatal mortality rate, 30% in postpartum hemorrhage incidence rate, and 48% in neonatal asphyxia incidence rate in TSAM hospitals relative to control hospitals. However, the stillbirth rate did not decline following the TSAM intervention. We found that a quality improvement strategy that employed continuous quality improvement approaches using onsite clinical mentorship of health providers along with involvement of health facility leadership to facilitate the improvement was associated with improvements in MNH in Rwanda. Our findings provide evidence that can justify the scale up of TSAM across the country and potentially in other similar settings.
Poor quality of healthcare is currently a bigger driver of excess maternal and neonatal mortality than under-utilization of health facilities in many low– and middle-income countries (LMICs).
Achieving maternal and newborn health related Sustainable Development Goal targets will require high-quality health systems in LMICs.
The Training, Support and Access Model (TSAM) clinical mentorship implemented in 10 Rwandan district hospitals to bolster quality of care provided to women and newborns was associated with a reduction in in-hospital maternal and newborn deaths. However, the (intrapartum) stillbirth rate did not decline following the TSAM intervention.
The TSAM intervention was associated with a significant decline in in-hospital maternal and neonatal morbidity (e.g., incidence of postpartum hemorrhage and neonatal asphyxia).
Employing continuous quality improvement approaches using onsite clinical mentorship of health providers along with involvement of health facility leadership to facilitate the improvement can be an effective strategy to improve maternal and newborn health outcomes.
Quasi-experimental methods leveraging routine health information systems data can be useful to study impact of health system improvement interventions in low-resource settings.
Competing Interest Statement
Drs. Hategeka, Lynd, Kenyon, Ngabonzima, Luginaah and Cechetto were involved in the development and / or implementation of TSAM in Rwanda.
Funding Statement
Dr. Hategeka received support through a Vanier Canada Graduate Scholarship and a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research. Dr. Cechetto was awarded the grant from Global Affairs Canada that supported the development and implementation of TSAM in Rwanda. Dr. Law received salary support through a Canada Research Chair in Access to Medicines and a Michael Smith Foundation for Health Research Scholar Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of British Columbia Behavioural Research Ethics Board gave ethical approval for this work (Certificate # H18-02591).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos